A detailed history of Royce & Associates LP transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Royce & Associates LP holds 124,011 shares of HALO stock, worth $5.9 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
124,011
Previous 176,727 29.83%
Holding current value
$5.9 Million
Previous $9.25 Million 23.33%
% of portfolio
0.07%
Previous 0.09%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$51.3 - $64.42 $2.7 Million - $3.4 Million
-52,716 Reduced 29.83%
124,011 $7.09 Million
Q2 2024

Aug 13, 2024

SELL
$37.81 - $52.4 $560,646 - $776,987
-14,828 Reduced 7.74%
176,727 $9.25 Million
Q1 2024

May 13, 2024

BUY
$33.68 - $41.95 $1.76 Million - $2.19 Million
52,245 Added 37.5%
191,555 $7.79 Million
Q4 2023

Feb 12, 2024

BUY
$33.32 - $42.1 $4.64 Million - $5.86 Million
139,310 New
139,310 $5.15 Million
Q1 2023

May 04, 2023

SELL
$32.86 - $55.7 $1.68 Million - $2.84 Million
-51,000 Reduced 53.13%
45,000 $1.72 Million
Q4 2022

May 23, 2023

BUY
$40.06 - $59.44 $2.04 Million - $3.03 Million
51,000 Added 113.33%
96,000 $5.46 Million
Q2 2022

Aug 04, 2022

BUY
$37.35 - $48.3 $2.39 Million - $3.09 Million
64,000 Added 200.0%
96,000 $4.22 Million
Q1 2022

May 05, 2022

BUY
$31.97 - $41.06 $1.02 Million - $1.31 Million
32,000 New
32,000 $1.28 Million

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.62B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Royce & Associates LP Portfolio

Follow Royce & Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.